Quick Summary
Bearberry (Arctostaphylos uva-ursi) is a plant traditionally used for urinary tract-related conditions, containing bioactive compounds such as arbutin. It has been studied for its potential antimicrobial, anti-inflammatory, antioxidant, and anti-adhesive properties, particularly in the management of urinary tract infections (UTIs). Current clinical evidence is limited, and more high-quality trials are needed to confirm therapeutic benefits and safety profiles.
What is it?
Bearberry is a low-growing evergreen shrub native to northern and temperate regions of the Northern Hemisphere. Its leaves have been used in traditional herbal medicine, mainly for supporting urinary tract health. The plant contains several bioactive compounds, with arbutin being the most notable.
Traditional Uses
- Supporting urinary tract health
- Relieving symptoms related to urinary tract infections
- Anti-inflammatory applications in folk medicine
- Use as a mild diuretic
Active Compounds
Key bioactive compounds in bearberry include:
- Arbutin: A glycoside with antimicrobial and anti-adhesive properties against certain uropathogens.
- Phenolic compounds: Contribute to antioxidant and anti-inflammatory effects.
- Other phytochemicals common to the Ericaceae family that may influence metabolic pathways.
Potential Benefits with Evidence Levels
- Urinary tract infection prevention and management: Preclinical and limited clinical evidence. Bearberry’s arbutin content shows anti-adhesive and antimicrobial activity against uropathogens. Some reviews suggest it may serve as an adjunctive option for UTI prevention, especially recurrent infections in women, including postmenopausal women. However, most data come from in vitro, preclinical, or traditional use sources, with few rigorous clinical trials. Effectiveness as a stand-alone or combined therapy requires further research.
- Antimicrobial and anti-inflammatory effects: Supported by in vitro and phytochemical evidence. Bearberry extracts demonstrate antioxidant and anti-inflammatory activity, which may support its traditional use although strong clinical trial data are lacking.
- Potential complementary role in diabetes management: Preclinical and indirect evidence. Due to shared phytochemicals with related plants known for glucose modulation, bearberry might have potential benefits in diabetes management. Direct evidence is currently lacking.
Side Effects
Available data suggest that bearberry extracts at traditional dosage levels are generally well tolerated. In vitro safety assessments indicate low cytotoxicity at typical dosages. There are no systematic reports of significant adverse effects. However, isolated in vitro findings suggest possible cytostatic effects of arbutin on lymphocyte proliferation, which indicates a need for caution and further safety studies.
Drug Interactions
Currently, no specific clinically significant herb-drug interactions have been documented for bearberry. Nonetheless, because bearberry and related herbal preparations may influence cytochrome P450 enzymes and P-glycoprotein transporters, caution is advised when used concurrently with medications metabolized via these pathways. Further research is necessary to clarify potential interaction risks.
Who Should Avoid It
- Individuals with kidney disease or impaired renal function should avoid bearberry unless under professional supervision due to lack of safety data.
- Pregnant or breastfeeding women should avoid bearberry or use only under medical advice, as safety has not been established.
- People planning long-term or high-dose use should exercise caution due to limited safety information.
Evidence Limitations
The majority of studies on bearberry are preclinical, in vitro, or based on traditional uses and phytochemical analyses. There is a lack of robust randomized controlled trials in humans, which limits firm conclusions regarding its efficacy and safety. Standardization of extracts, appropriate dosing, and well-defined clinical endpoints are needed in future research. Long-term safety data, particularly for vulnerable populations such as pregnant women and children, remain unestablished.
References
- Cipriani C, et al. Bioactive Compounds as Alternative Approaches for Preventing Urinary Tract Infections in the Era of Antibiotic Resistance. 2025.
- Hsu YT, et al. Plant Extracts and Natural Compounds for the Treatment of Urinary Tract Infections in Women: Mechanisms, Efficacy, and Therapeutic Potential. 2025.
- Chamodini K, et al. Bioactive Compounds in Natural Remedies and Functional Foods for Managing Recurrent Urinary Tract Infections in Postmenopausal Women. 2025.
- Jurica K, et al. In vitro safety assessment of the strawberry tree (Arbutus unedo L.) water leaf extract and arbutin in human peripheral blood lymphocytes. 2018.
- Husain I, et al. Screening of medicinal plants for possible herb-drug interactions through modulating nuclear receptors, drug-metabolizing enzymes and transporters. 2023.
- Lapi F, et al. Use, Attitudes and Knowledge of Complementary and Alternative Drugs (CADs) Among Pregnant Women: a Preliminary Survey in Tuscany. 2010.
- Salm S, et al. Current state of research on the clinical benefits of herbal medicines for non-life-threatening ailments. 2023.
Last Reviewed
April 2024
Disclaimer: This information is provided for educational purposes only and is not intended as medical advice. Herb use may interact with medications or underlying health conditions. Always consult a healthcare professional before starting any new herbal product, especially if you are pregnant, breastfeeding, have a medical condition, or are taking other medications.